
NEW YORK – Medical device company Catheter Precision has rebranded as Flyte Aviation, effective Monday, following its acquisition of the private charter business Fly Flyte earlier this year.
The company also changed its NYSE ticker from VTAK to VJET. The rebranding reflects its shift toward aviation and technology, the company said Sunday.
Catheter Precision acquired Fly Flyte as part of a move into private aviation and is now building its business around a digital platform designed to simplify the discovery, pricing and booking of private aircraft.
It operates a growing fleet of Cirrus Vision Jets and has an FAA-certified Part 135 operating subsidiary, Ponderosa Air.
Flyte said the U.S. private jet charter market is worth about $11.6 billion in 2026 and is expected to grow at an annual rate of 6.9% through 2031, citing a September report by Fortune Business Insights.
During the fourth quarter, the company plans to invest in a mobile application, AI data analytics and customer acquisition as it expands its aviation business.
Flyte also said its existing life sciences operations, which include the LockeT and VIVO products, will continue and that it remains committed to funding ongoing research trials and studies.






















“This assessment will enable us to fund long-term leases of the new eco residence complex, located in Abu Dhabi’s Masdar City innovation precinct, and will serve as the foundation for Etihad to fund future sustainable initiatives.”
